Reiter syndrome triggered by adalimumab (Humira) and leflunomide (Arava) in a patient with ankylosing spondylarthropathy and Crohn disease

Br J Dermatol. 2007 Jan;156(1):188-9. doi: 10.1111/j.1365-2133.2006.07586.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Reactive / chemically induced*
  • Arthritis, Reactive / complications
  • Crohn Disease / drug therapy*
  • Humans
  • Isoxazoles / adverse effects*
  • Leflunomide
  • Male
  • Spondylarthropathies / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Isoxazoles
  • Adalimumab
  • Leflunomide